Stallion India Fluorochemicals Q1 FY27 earnings call

Stallion India Fluorochemicals Limited reported a strong Q1 FY27, with total revenue reaching ₹124.68 crores, marking a 12.78% year-on-year growth. EBITDA saw a significant increase of 75.85% to ₹25.27 crores, resulting in an EBITDA margin of 20.27%. Profit After Tax (PAT) also surged by 79.15% to ₹18.57 crores, with a PAT margin of 14.90%. Management noted that these strong margins were partly attributable to a favorable product mix, better planning, and approximately 50% from inventory gains during the Gulf crisis, suggesting they may not be continuously repeatable.

The company is actively pursuing several capacity expansion projects. The Khalapur high purity helium processing plant, with an installed capacity of 1200 metric tons per annum, has completed preparations and is expected to commence commercial operations in Q2 FY27. The Mambattu facility in Andhra Pradesh, designed for refrigerant de-bulking, blending, and storage, is progressing as planned and is targeted to begin operations by the end of 2026. The 10,000 metric ton R32 manufacturing facility at Bhilwara, a key backward integration project, is now expected to be completed by December 2026, a delay from the earlier July 2026 target due to funding challenges.

Stallion aims to increase contribution from higher-value products like HFO and other specialty gases. The R32 facility is crucial for backward integration, reducing dependence on external sourcing, and improving supply reliability and margins. The company plans to announce its next major project, an HFO plant with a CAPEX of ₹350-400 crores and a capacity of 10,000 tons, towards the end of 2026, after the R32 plant is commissioned. This strategic shift is expected to improve EBITDA margins by 3-4% over the medium term^⏳.

While Q1 FY27 saw impressive EBITDA margins of 20.27% and PAT margins of 14.90%, management clarified that this was a 'special quarter' partly driven by inventory gains and better planning during the Gulf crisis. They expect margins to continuously improve but not necessarily at the Q1 rate. The newer business segments, such as R32 manufacturing, are projected to have a PAT margin of around 24%, significantly higher than the conventional business's 10% PAT margin, which will lead to an overall margin expansion as the product mix shifts.

The company is evaluating its capital raising strategy for future growth. While previously committed to avoiding equity dilution, management now indicates that considering 'some dilution, some debt' might be more prudent to achieve a 'scorching pace' of growth and meet ambitious revenue targets like exceeding ₹1100 crores by FY28. This revised stance is driven by the need to fund multiple large-scale projects like the R32 and upcoming HFO plants, which require substantial capital for technology transfer, planning, and execution.

The newly operational Khalapur helium plant is expected to contribute approximately 12% to the company's revenue in FY27. Management provided a ramp-up schedule, expecting 5 containers in the current half-year, 12 containers next year (FY28), and 24 thereafter. Despite the 1200 metric ton capacity, utilization is projected to be around 20% in FY28, indicating a gradual ramp-up. The helium market faces a shortfall and higher pricing over the next 2-3 years, but Stallion has de-risked its supply through tie-ups and strategic sourcing, ensuring availability.

Management highlighted a significant potential overcapacity in the Indian R32 market, with upcoming manufacturing capacities (70,000-90,000 tons) far exceeding the current domestic demand of 20,000 tons. This implies that a substantial portion of the production will need to be directed towards exports, blending, and tie-ups. They also noted the trend of 'swing plants' that can shift production between different refrigerants (e.g., R32, 125, 124a) based on market demand and GWP regulations, suggesting flexibility will be key to navigating potential oversupply.